Figure 1From: A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatmentsSystemic therapy treatment patterns. Treatment patterns according to (A) therapy line, and (B) second-line and third-line systemic therapy received according to histological subtype. *Patients were required to have at least one second-line systemic therapy for soft tissue sarcomas to be eligible for this study. Therefore, the first-line therapy distribution was based on those patients receiving at least one additional line of therapy (i.e. second-line or second-line plus additional lines of therapy).Back to article page